Page last updated: 2024-08-18

1,3-ditolylguanidine and erythrosine

1,3-ditolylguanidine has been researched along with erythrosine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ajmo, CT; Collier, L; Cuevas, J; Pennypacker, KR; Vernon, DO	1

Other Studies

1 other study(ies) available for 1,3-ditolylguanidine and erythrosine

Article	Year
Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats. Current neurovascular research, 2006, Volume: 3, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Anticonvulsants; Biomarkers; Brain; Brain Ischemia; Cell Survival; Disease Models, Animal; DNA-Binding Proteins; Encephalitis; Fluoresceins; Gliosis; Guanidines; Infarction, Middle Cerebral Artery; Male; Nerve Degeneration; Nerve Tissue Proteins; Neuroglia; Neuroprotective Agents; Nuclear Proteins; Organic Chemicals; Rats; Rats, Sprague-Dawley; Receptors, sigma; Time Factors; Treatment Outcome	2006

Article

Year

Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats.

Current neurovascular research, 2006, Volume: 3, Issue:2

Topics: Animals; Anti-Inflammatory Agents; Anticonvulsants; Biomarkers; Brain; Brain Ischemia; Cell Survival; Disease Models, Animal; DNA-Binding Proteins; Encephalitis; Fluoresceins; Gliosis; Guanidines; Infarction, Middle Cerebral Artery; Male; Nerve Degeneration; Nerve Tissue Proteins; Neuroglia; Neuroprotective Agents; Nuclear Proteins; Organic Chemicals; Rats; Rats, Sprague-Dawley; Receptors, sigma; Time Factors; Treatment Outcome

2006